Saturday, August 20, 2011

Melanoma Drug Approved by FDA

But it won't work for Meagan. It targets a genetic mutation she does not have. It does illustrate the direction cancer drug research is heading - moving from slash, burn and poison to smarter targeting of individual mutations.

No comments:

Post a Comment